Diazepam at the Active Phase of Labor

September 3, 2014 updated by: Yunhai Chuai, Navy General Hospital, Beijing

Intravenous Injection of Diazepam at the Beginning of Active Phase of Labor

Prolonged labour can lead to increased maternal and neonatal mortality and morbidity due to increased risks of maternal exhaustion, postpartum haemorrhage and sepsis, fetal distress and asphyxia and requires early detection and appropriate clinical response. The risks for complications of prolonged labour are much greater in poor resource settings. Active management of labour versus physiological, expectant management, has shown to decrease the occurrence of prolonged labour. Administering sedatives during labour could also lead to faster and more effective dilatation of the cervix. Interventions to shorten labour, such as sedatives, can be used as a preventative or a treatment strategy in order to decrease the incidence of prolonged labour. As the evidence to support this is still largely anecdotal around the world. (Cochrane Database of Systematic Reviews 2013,CD009243.pub3.; Cochrane Database of Systematic Reviews 2012, CD009223.pub2.)

Hypothesis: Diazepam reduced the duration of labor and the severity of pain in labor.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

400

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100048
        • Navy General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 31 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • primigravida
  • at term
  • singleton pregnancy
  • cephalic presentation
  • spontaneous labour
  • intact membranes at the beginning of active phase

Exclusion Criteria:

  • induced labour
  • spontaneous rupture of membranes at randomisation
  • obstetric complications, or medical complications
  • previous uterine scarring, or cervical surgery
  • cervical dilatation of more than 5 cm
  • other antispasmodics in the first stage
  • malpresentation, macrosomia, cephalopelvic disproportion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: normal saline, active phase of labor
A single dose intravenous injection of normal saline (2ml) at the beginning of active phase of labor in the group.
A single dose intravenous injection of normal saline (2ml)/diazepam (10mg, 2ml) at the beginning of active phase of labor.
Experimental: diazepam, active phase of labor
A single dose intravenous injection of diazepam (10mg, 2ml) at the beginning of active phase of labor in the group.
A single dose intravenous injection of normal saline (2ml)/diazepam (10mg, 2ml) at the beginning of active phase of labor.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of labor
Time Frame: labor
Duration of first stage of labor. Duration of second stage of labour. Duration of third stage of labor. Total duration of labor.
labor

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of cervical dilatation
Time Frame: at the active phase of labor
at the active phase of labor
Pain relief
Time Frame: every 30 minutes during the 3-hour period after administration of the trial drug
Pain severity during the last contraction was assessed using a Visual Analogue Scale (VAS) (with anchor points of 0 = no pain at all and 10 = the most excruciating pain) every 30 minutes during the 3-hour period after administration of the trial drug. This information was used to derive measures of pain relief at each time-point using absolute change in pain intensity (on a 10-cm VAS) from pre-analgesia (baseline). In addition to analysing all the time-points together (as described in the section on statistical analysis), a specific analysis of pain relief at 60 minutes was conducted, because it was anticipated that the maximum analgesic effect would occur then. (Wee MYK, Tuckey JP, Thomas PW, Burnard S. A comparison of intramuscular diamorphine and intramuscular pethidine for labour analgesia: a two-centre randomised blinded controlled trial. BJOG 2014;121:447-456.)
every 30 minutes during the 3-hour period after administration of the trial drug
Type of delivery
Time Frame: post partum, immediately
post partum, immediately

Other Outcome Measures

Outcome Measure
Time Frame
Maternal adverse events
Time Frame: two weeks after childbirth
two weeks after childbirth
Neonatal adverse events
Time Frame: two weeks after childbirth
two weeks after childbirth
Maternal satisfaction
Time Frame: post partum, immediately
post partum, immediately

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aiming Wang, Dr, Navy General Hospital, Beijing

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Anticipated)

September 1, 2015

Study Completion (Anticipated)

September 1, 2015

Study Registration Dates

First Submitted

August 30, 2014

First Submitted That Met QC Criteria

September 3, 2014

First Posted (Estimate)

September 4, 2014

Study Record Updates

Last Update Posted (Estimate)

September 4, 2014

Last Update Submitted That Met QC Criteria

September 3, 2014

Last Verified

September 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on normal saline/diazepam at the active phase of labor

Subscribe